Author (Corporate) | European Commission: DG Communication |
---|---|
Series Title | Press Release |
Series Details | IP/17/2182 (27.07.17) |
Publication Date | 27/07/2017 |
Content Type | News |
Background and further information: These transactions are related to the Dow/DuPont merger divestment commitments, following the companies' merger in March 2017. DuPont committed to divest major parts of its global crop protection business, including its global research and development organisation, which FMC decided to acquire. As part of the deal, FMC is selling its Health and Nutrition business to DuPont. FMC's acquisition of parts of DuPont's crop protection business is conditional on the divestment of FMC's sulfonylurea and florasulam businesses in the EEA. DuPont's acquisition of FMC's Health & Nutrition business is conditional upon the divestment of DuPont's global alginates business. FMC's acquisition of parts of DuPont's crop protection business was notified to the Commission on 8 June 2017. DuPont's acquisition of FMC's Health & Nutrition business was notified to the Commission on 7 June 2017. The European Commission decided on 27 July 2017 to conditionally approve, under the EU Merger Regulation, FMC's proposed acquisition of parts of DuPont's crop protection business and DuPont's acquisition of FMC's Health and Nutrition business. |
|
Source Link | Link to Main Source http://europa.eu/rapid/press-release_IP-17-2182_en.htm |
Related Links |
|
Subject Categories | Business and Industry, Internal Markets |
Countries / Regions | Europe |